Tortugas Neuroscience Reports Positive Phase 2b Results for Obuprazine in Schizophrenia, Showing Significant Symptom Improvements and Rapid Clinical Response Tortugas Neuroscience, a clinical-stage biotechnology company focused on developing transformative therapies…
VITALiS Expands Collaboration With Applied BioCode to Support In-House Gastrointestinal Pathogen Testing VITALiS and Applied BioCode have announced an expanded collaboration aimed at increasing the adoption of gastrointestinal (GI) pathogen…
Rubedo Life Sciences Reports Phase 1b Data Showing Reduced Skin Epigenetic Age and Inflammatory Biomarkers With RLS-1496 Rubedo Life Sciences, a clinical-stage biotechnology company developing therapeutics designed to rejuvenate cellular…
Stoke Therapeutics Presents STK-002 Preclinical and Clinical Data at AAO 2026, Advancing RNA-Based Approach for Autosomal Dominant Optic Atrophy Stoke Therapeutics, Inc., a biotechnology company focused on restoring protein expression…
Catalent Partners with Mantra to Develop and Manufacture Single-Serve OTC Oral Gel Products Catalent, Inc., a leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better…
TG Therapeutics Publishes Five-Year Comparative Analysis Showing Favorable Long-Term Outcomes for BRIUMVI in Relapsing Multiple Sclerosis TG Therapeutics, Inc. has announced the publication of results from a five-year matching-adjusted indirect…
Bristol Myers Squibb Reports Positive Phase 3 ALOFT-IPF Results for Admilparant in Idiopathic Pulmonary Fibrosis Bristol Myers Squibb has announced topline results from its pivotal Phase 3 ALOFT-IPF clinical trial…
Bausch + Lomb Appoints Thomas J. Appio as Interim CEO as Brent Saunders Departs Bausch + Lomb Corporation, a leading global eye health company, and its parent company, Bausch Health…
BIOMAG™-LL Study Completes Enrollment for Longer Freesolve™ Magnesium Scaffolds Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies, has announced the successful completion of patient enrollment in the BIOMAG™-LL…
Final MINT Study Results Highlight Real-World Benefits of Mogamulizumab in Mycosis Fungoides and Sézary Syndrome Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE: 4151),…
bioAffinity Technologies Closes $4 Million Registered Direct Offering to Support CyPath® Lung Sales and Corporate Operations bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company developing noninvasive healthcare solutions for…
Corcym Reports Positive Seven-Year Mid-Term Data for Perceval Plus Sutureless Aortic Valve in MANTRA Clinical Study Corcym, a global medical device company focused on cardiac surgery, has announced positive mid-term…